or Try an Advanced Search...

    ETF Components for VGK - Vanguard FTSE European ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVS D 0.41 1.80
    HSBH B -0.30 1.38
    UL D 1.70 1.22
    ABBV D 3.04 0.71
    DEO F 1.69 0.56
    BCS C -2.63 0.37
    LYG F -1.44 0.35
    FLUT A 0.00 0.34
    E F 0.42 0.28
    STLA F 1.56 0.22
    SW A 0.48 0.22
    LOGI D 0.15 0.10
    QGEN D 1.06 0.08
    FRO F 0.10 0.02
    FLNG B 0.61 0.01
    TRMD F 0.83 0.01
    GOGL F -0.45 0.01
    GEN B 1.27 0.00

    Represented by ETF Holdings

    Keywords: S&P 500 Ships Tanker Banking Biotechnology Eye Care Products General Insurance Insurance Products Liquefied Natural Gas Maritime Transport Molecular Diagnostics Natural Gas Petroleum Products Pharmaceutical Acid Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Alcohol Alcoholic Drinks
    Industries: Shipping & Ports Drug Manufacturers - Major Auto Manufacturers Banks - Global Banks - Regional - Europe Beverages - Wineries & Distilleries Computer Systems Diagnostics & Research Gambling Household & Personal Products Oil & Gas Integrated Oil & Gas Midstream Packaging & Containers Software - Application

    Recent News for Vanguard FTSE European ETF & its Holdings

    Date Stock Title
    Nov 22 STLA Why F1's Las Vegas Grand Prix will be 'bigger and better' than last year
    Nov 22 FLUT Flutter stock gets Buy rating from Goldman Sachs
    Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
    Nov 22 BCS Dollar on Longest Winning Run in a Year on Trump Presidency
    Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
    Nov 22 NVS Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
    Nov 22 GEN Is Gen Digital Inc. (GEN) An Undervalued Cybersecurity Stock to Buy?
    Nov 22 NVS Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
    Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
    Nov 22 UL Unilever CEO says will slim down, not spin off food business - FT
    Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
    Nov 22 FRO Stocks to watch next week: Dell, Analog Devices, Manchester United, Urban Outfitters and easyJet
    Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
    Nov 22 QGEN Innovations Support QIAGEN Shares Despite Macroeconomic Concerns
    Nov 22 GEN Gen Digital: A Robust Business Facing A Secular Threat
    Nov 22 DEO Drinks M&A recovery set to continue in 2025
    Nov 22 LOGI Logitech: Margin Expansion Offers Valuation Opportunity
    Nov 22 BCS Best savings accounts that offer above-inflation rates, 22 November
    Nov 22 STLA Stellantis may revise Mexico manufacturing strategy amid potential US tariffs
    Nov 22 NVS Novartis provides updates to mid-term guidance, now sees 6% sales CAGR 2023-2028
    The investment seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe. The fund employs an indexing investment approach by investing all, or substantially all, of its assets in the common stocks included in the FTSE Developed Europe Index. The FTSE Developed Europe Index is made up of approximately 497 common stocks of companies located in 17 European countries-mostly companies in the United Kingdom, France, Switzerland, and Germany (which made up approximately 34%, 15%, 14%, and 13%, respectively, of the index's market capitalization as of May 31, 2013).
    Stock Market Index MSCI EAFE Ftse Developed Europe Index Financials Ftse Developed Europe Index
    Back to the Main VGK Page...